CVS vs HOTH · P/E 16, rev $402.07B vs rev $1.24B
CVS Health Corp (CVS) versus Hoth Therapeutics Inc (HOTH) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. HOTH currently screens at market cap $15.5M.
Not investment advice. Open the CVS and HOTH stock pages for the full models.
Not investment advice.